ImmunityBio Ownership | Who Owns ImmunityBio?

Overview Forecast RevenueFinancials Chart Transcripts

ImmunityBio Ownership Summary

ImmunityBio is owned by 19.89% institutional investors, 62.17% insiders, and 17.94% retail investors. Vanguard group is the largest institutional shareholder, holding 3.46% of IBRX shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 1.16% of its assets in ImmunityBio shares.

IBRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ImmunityBio	19.89%	62.17%	17.94%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	32.78M	3.46%	$64.90M
Blackrock funding, inc. /de	34.08M	3.32%	$298.40M
State street	21.40M	2.08%	$187.34M
Blackrock	11.42M	1.70%	$72.19M
Vanguard capital management	15.69M	1.53%	$137.38M
D. e. shaw	11.55M	1.12%	$101.13M
Two sigma investments, lp	11.10M	1.08%	$97.16M
Geode capital management	9.85M	0.96%	$86.23M
Heights capital management	6.57M	0.74%	$16.15M
Millennium management	5.58M	0.54%	$48.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Heights capital management	6.57M	4.43%	$16.15M
Pharvision advisers	11.20K	1.85%	$98.04K
Kercheville advisors	644.68K	1.72%	$5.64M
Legacy capital group california	446.00K	1.18%	$3.90M
Mfg wealth management	173.88K	1.09%	$1.52M
Nia impact advisors	270.17K	0.98%	$2.37M
Vestor capital	44.84K	0.76%	$12.05M
Davidson kahn capital management	163.09K	0.61%	$1.43M
Allen inc /ny	687.57K	0.59%	$6.02M
Winning points advisors	722.37K	0.54%	$509.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	34.08M	0.00%	7.74M
Two sigma investments, lp	11.10M	0.07%	6.71M
Heights capital management	6.57M	4.43%	6.57M
Vanguard group	32.78M	0.00%	5.12M
Millennium management	5.58M	0.02%	4.16M

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-7.76M
Hrt financial lp	-	-	-3.93M
Cormorant asset management, lp	-	-	-3.00M
Tang capital management	-	-	-2.33M
Octagon capital advisors lp	-	-	-1.72M

New Positions

Holder	Shares	% Assets	Change	Value
Heights capital management	6.57M	4.43%	6.57M	$16.15M
Sixth street partners management company	2.89M	0.00%	2.89M	$25.29M
First trust advisors lp	1.21M	0.01%	1.21M	$10.63M
Winning points advisors	722.37K	0.54%	722.37K	$509.00K
Trexquant investment lp	696.55K	0.04%	696.55K	$6.10M

Sold Out

Holder	Change
Assetmark	-1.00
Investors research	-15.00
Financial gravity asset management	-17.00
True wealth design	-20.00
Nelson, van denburg & campbell wealth management group	-26.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	434	3.83%	204,274,231	14.35%	19	6.57%	203	-30.24%	107	81.36%
Mar 31, 2026	226	-20.14%	59,534,423	-64.77%	6	2.03%	166	16.90%	29	-54.69%
Dec 31, 2025	199	-27.11%	140,741,730	-1.64%	14	5.73%	97	-28.68%	42	-27.59%
Sep 30, 2025	181	-26.42%	94,869,384	-19.91%	10	6.01%	85	-45.51%	42	23.53%
Jun 30, 2025	254	15.45%	123,819,651	52.36%	13	15.36%	159	32.50%	37	-13.95%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	12.27M	1.16%	28.18K
Vanguard Total Stock Mkt Idx Inv	11.60M	1.11%	103.03K
Vanguard Morn Total Stk Mkt Idx Investor	11.60M	1.11%	103.03K
Vanguard MStar Total Stk Mkt Idx Invest	11.64M	1.10%	39.24K
iShares Russell 2000 ETF	9.74M	0.92%	-172.99K
Vanguard Small Cap Index	8.43M	0.80%	21.88K
Vanguard US Total Market Shares ETF	5.72M	0.67%	1.43M
Vanguard Morn Small Cap Growth Index Inv	4.85M	0.46%	204.48K
Vanguard Small Cap Growth Index Inv	4.85M	0.46%	204.48K
Vanguard MStar Small Cap Growth Indx Inv	4.86M	0.46%	10.69K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 02, 2026	Cohen Cheryl	-	Sell	$1.25M
Jul 01, 2026	Selecky Christobel	-	Sell	$1.44M
Jun 30, 2026	Selecky Christobel	-	Sell	$9.00K
Jun 29, 2026	Selecky Christobel	-	Sell	$862.22K
Jun 24, 2026	Simon Barry J.	-	Sell	$196.91K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	4
2026 Q1	-	8
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-

IBRX Ownership FAQ

Who Owns ImmunityBio?

ImmunityBio shareholders are primarily institutional investors at 19.89%, followed by 62.17% insiders and 17.94% retail investors. The average institutional ownership in ImmunityBio's industry, Biotech Stocks , is 379.61%, which ImmunityBio falls below.

Who owns the most shares of ImmunityBio?

ImmunityBio’s largest shareholders are Vanguard group (32.78M shares, 3.46%), Blackrock funding, inc. /de (34.08M shares, 3.32%), and State street (21.4M shares, 2.08%). Together, they hold 8.87% of ImmunityBio’s total shares outstanding.

Does Blackrock own ImmunityBio?

Yes, BlackRock owns 1.70% of ImmunityBio, totaling 11.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 72.19M$. In the last quarter, BlackRock increased its holdings by 1.05M shares, a 10.10% change.

Who is ImmunityBio’s biggest shareholder by percentage of total assets invested?

Heights capital management is ImmunityBio’s biggest shareholder by percentage of total assets invested, with 4.43% of its assets in 6.57M ImmunityBio shares, valued at 16.15M$.

Who is the top mutual fund holder of ImmunityBio shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of ImmunityBio shares, with 1.16% of its total shares outstanding invested in 12.27M ImmunityBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools